Boston Scientific has introduced a new version of pre-dilatation balloon catheter in the US, designed to offer enhanced deliverability and expanded options for treating coronary artery lesions.
The Emerge percutaneous transluminal coronary angioplasty (PTCA) catheter, which is available in balloon diameters ranging from 1.5 mm up to 4.0 mm and lengths from 8 mm up to 30 mm, includes Monorail and over-the-wire (OTW) options.
The Monorail and OTW catheters use push technology (1.5 mm) to offer a single-segment inner shaft for enhanced pushability and workhorse technology (1.5 mm to 4.0 mm) to provide bi-segment inner shaft for excellent deliverability without sacrificing push.
Wake Heart & Vascular spokesperson Tift Mann said the pre-dilatation balloon catheter combines Boston Scientific’s balloon technologies into a single platform.
"The result is exceptional deliverability and reliable performance in a wide range of anatomy and lesion types," Mann added.
Boston Scientific interventional cardiology division president Kevin Ballinger said, "The Emerge Balloon Catheter further enhances the Boston Scientific portfolio by offering a versatile platform with a range of options and features that allow physicians to select the appropriate balloon based on clinical need."